Home/Teclison/Robert R. Ruffolo, PhD
RR

Robert R. Ruffolo, PhD

Scientific and Strategic Advisor

Teclison

Therapeutic Areas

Teclison Pipeline

DrugIndicationPhase
TEC-001 (with TATE)Colorectal CancerPhase 2
TEC-001 + OpdivoLiver Cancer (Advanced stage)Phase 2
TEC-001 + KeytrudaLung CancerPhase 2
TEC-002Solid TumorsPreclinical
TEC-003Solid TumorsPreclinical